Correlation Between Fortress Biotech and Aceragen

Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Aceragen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Aceragen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fortress Biotech and Aceragen, you can compare the effects of market volatilities on Fortress Biotech and Aceragen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Aceragen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Aceragen.

Diversification Opportunities for Fortress Biotech and Aceragen

-0.37

Correlation Coefficient

Fortress Biotech  Aceragen

Very good diversification

The 3 months correlation between Fortress and Aceragen is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Aceragen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aceragen and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Aceragen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aceragen has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Aceragen go up and down completely randomly.

Pair Corralation between Fortress Biotech and Aceragen

Given the investment horizon of 90 days Fortress Biotech is expected to generate 0.6 times more return on investment than Aceragen. However, Fortress Biotech is 1.66 times less risky than Aceragen. It trades about -0.03 of its potential returns per unit of risk. Aceragen is currently generating about -0.11 per unit of risk. If you would invest  1,560  in Fortress Biotech on October 7, 2024 and sell it today you would lose (1,337) from holding Fortress Biotech or give up 85.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	26.41%
Values	Daily Returns

Fortress Biotech  vs.  Aceragen

Fortress Biotech

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Aceragen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aceragen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Aceragen is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Fortress Biotech and Aceragen

The main advantage of trading using opposite Fortress Biotech and Aceragen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Aceragen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aceragen will offset losses from the drop in Aceragen's long position.

The idea behind Fortress Biotech and Aceragen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..